Cargando…

Rapid Initiation of Antiretroviral Therapy Following Diagnosis of Human Immunodeficiency Virus Among Patients with Commercial Insurance Coverage

BACKGROUND: New guidelines for the treatment of human immunodeficiency virus (HIV) advocate for rapid initiation of antiretroviral therapy (ART) ≤ 7 days after HIV diagnosis with agents that have a high genetic barrier to resistance, good tolerability, and convenient dosing. OBJECTIVE: To describe c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benson, Carmela, Emond, Bruno, Lefebvre, Patrick, Lafeuille, Marie-Hélène, Côté-Sergent, Aurélie, Tandon, Neeta, Chow, Wing, Dunn, Keith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391294/ https://www.ncbi.nlm.nih.gov/pubmed/31747358 http://dx.doi.org/10.18553/jmcp.2019.19175

Ejemplares similares

Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus
por: Benson, Carmela, et al.
Publicado: (2020)

Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV
por: Dunn, Keith, et al.
Publicado: (2018)

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
por: Patel, Charmi, et al.
Publicado: (2019)

Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study
por: Emond, Bruno, et al.
Publicado: (2021)

Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide
por: Chow, Wing, et al.
Publicado: (2020)

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
por: Pilon, Dominic, et al.
Publicado: (2017)

Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate
por: Emond, Bruno, et al.
Publicado: (2018)

Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics
por: Pilon, Dominic, et al.
Publicado: (2021)

Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States
por: Emond, Bruno, et al.
Publicado: (2022)

Respiratory Syncytial Virus–Related Complications and Healthcare Costs Among a Medicare-Insured Population in the United States
por: DeMartino, Jessica K, et al.
Publicado: (2023)

Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis
por: Vanderpoel, Julie, et al.
Publicado: (2023)

1460. Respiratory Syncytial Virus (RSV)-Related Clinical Events among a Medicare-Insured Population in the United States
por: DeMartino, Jessica K K, et al.
Publicado: (2022)

Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies
por: Correll, Christoph U., et al.
Publicado: (2023)

Incidence of cardiometabolic outcomes among people living with HIV‐1 initiated on integrase strand transfer inhibitor versus non‐integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States
por: Rebeiro, Peter F., et al.
Publicado: (2023)

Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics
por: Lafeuille, Marie-Hélène, et al.
Publicado: (2018)

Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors
por: Wysham, Carol H., et al.
Publicado: (2017)

Adherence to Antiretroviral Treatment and Correlation with Risk of Hospitalization among Commercially Insured HIV Patients in the United States
por: Sax, Paul E., et al.
Publicado: (2012)

A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia
por: Lin, Dee, et al.
Publicado: (2023)

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy
por: Lee, Jeannette Y., et al.
Publicado: (2016)

Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
por: Fu, Alex Z., et al.
Publicado: (2022)

Analysis of a Commercial Insurance Policy to Deny Coverage for Emergency Department Visits With Nonemergent Diagnoses
por: Chou, Shih-Chuan, et al.
Publicado: (2018)

Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis
por: Lin, Dee, et al.
Publicado: (2021)

Association Between Prescription Cost Sharing and Adherence to Initial Combination Antiretroviral Therapy in Commercially Insured Antiretroviral-Naïve Patients with HIV
por: Johnston, Stephen S., et al.
Publicado: (2012)

Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral Therapy
por: McComsey, Grace A., et al.
Publicado: (2022)

Adherence to antiretroviral treatment regimens and correlation with risk of hospitalization among commercially insured HIV patients in the US
por: Sax, PE, et al.
Publicado: (2010)

A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States
por: Juday, Timothy, et al.
Publicado: (2011)

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
por: Fitzgerald, Timothy, et al.
Publicado: (2021)

PB2110: PREDICTORS OF FRONTLINE (FL) DOUBLET OR TRIPLET REGIMEN USE AMONG TRANSPLANT-INELIGIBLE (TIE) PATIENTS (PTS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) USING A MACHINE LEARNING APPROACH
por: Pianko, Matthew J., et al.
Publicado: (2023)

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
por: Lin, Dora H., et al.
Publicado: (2018)

CERN Health Insurance Scheme – Guarantee of health insurance coverage
Publicado: (2022)

Insurance Coverage Policies for Personalized Medicine
por: Hresko, Andrew, et al.
Publicado: (2012)

Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population
por: Mattingly, T. Joseph, et al.
Publicado: (2019)

The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation
por: Khorana, Alok A., et al.
Publicado: (2018)

2512. Decreasing Adherence to Antiretroviral Therapy over 4 Years of Follow-up in a Commercially-Insured Population of Patients with HIV
por: Priest, Julie, et al.
Publicado: (2019)

Transition Coverage and Clarity in Self-Insured Corporate Health Insurance Benefit Plans
por: Kirkland, Anna, et al.
Publicado: (2021)

Consumers' Knowledge about their Health Insurance Coverage
por: Marquis, M. Susan
Publicado: (1983)

Medicaid Expansions and the Insurance Coverage of Poor Teenagers
por: Leininger, Lindsey Jeanne
Publicado: (2009)

Americans' health insurance coverage, 1980-91
por: Levit, Katharine R., et al.
Publicado: (1992)

Sociodemographic patterns of health insurance coverage in Namibia
por: Allcock, Sophie H., et al.
Publicado: (2019)

Racial and Ethnic Disparities in Perinatal Insurance Coverage
por: Daw, Jamie R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4j2jd4ej8gle3j972enakcic5f